LDResearcher profile · from public sources
Li Ding
Targets
Filled chips are declared by the researcher; the others come from publications (number of works).
Now
Trials, publications and grants since Nov 2024.
Publication
African Genetic Similarity Is Associated with Reduced Inflammation and Enhanced Adaptive Immunity in Multiple Myeloma.
Blood, Oct 2026
Publication
Spatial Mapping of the Precancer-to-Cancer Transition in Breast and Prostate.
Cancer discovery, Sept 2026
Publication
Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets.
Nature cancer, Jun 2026
Publication
Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer.
Cancer research, Apr 2026
Publication
Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma.
Blood cancer discovery, Mar 2026
Publication
Biomarkers of response to neoadjuvant palbociclib plus anastrozole in endocrine-resistant estrogen receptor-positive/HER2-negative breast cancer: a phase 2 trial.
Nature communications, Jan 2026
Publication
Cellular senescence in human liver under normal aging and cancer.
Cell genomics, Jan 2026
Publication
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma.
Nature cancer, Jan 2026
Publication
Investigation of lncRNA expression in newly diagnosed multiple myeloma reveals a LINC01432-CELF2 axis as an inhibitor of apoptosis.
Oncogenesis, Oct 2025
Publication
RSK1 is an exploitable dependency in myeloproliferative neoplasms and secondary acute myeloid leukemia.
Nature communications, Jan 2025
Co-authors
Who links you
Enter another researcher's profile link or ID to see who has published with both of you.
You have published with Ryan C Fields directly.
Is this you? Request a correction or removal: support@frontlightresearch.com
Report an error